John Sundy Pandion Therapeutics, Inc. (PAND) insider trading activity
John Sundy is Chief Medical Officer of Pandion Therapeutics, Inc.. Currently has a direct ownership of 0 shares of PAND, which is worth approximately $0. The most recent transaction as insider was on Apr 01, 2021, when has been sold 115,826 shares (Common Stock) at a price of $60.0 per share, resulting in proceeds of $6,949,560. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
JS
John Sundy
Chief Medical Officer
Watertown, MA